Epicore BioNetworks Inc. (EBN):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Epicore BioNetworks Inc. (EBN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81724FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Epicore BioNetworks Inc. (Epicore BioNetworks) is a biochemical company. The company develops, manufactures and markets environmental biological products and specialty animal feeds to the aquaculture industry. It offers aquaculture products, agriculture products, municipal products, wastewater products, biological cleaning products, and bioremediation products. Epicore BioNetworks’ biological cleaning products include Epizym-DT, Epizym-DT liquid, Epizym-ST, Epizym-HS, and Epizym-CU, among others. The company offers a range of environmentally friendly biotech products to solve a variety of problems. It supplies products to aquaculture industry in Central and South America, among others. Epicore BioNetworks is headquartered in Eastampton, New Jersey, the US.

This comprehensive SWOT profile of Epicore BioNetworks Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Epicore BioNetworks Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Epicore BioNetworks Inc. – Key Information
Epicore BioNetworks Inc. – Overview
Epicore BioNetworks Inc. – Key Employees
Epicore BioNetworks Inc. – Key Employee Biographies
Epicore BioNetworks Inc. – Key Operational Heads
Epicore BioNetworks Inc. – Major Products and Services
Epicore BioNetworks Inc. – History
Epicore BioNetworks Inc. – Company Statement
Epicore BioNetworks Inc. – Locations And Subsidiaries
Epicore BioNetworks Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Epicore BioNetworks Inc. – Business Description
Epicore BioNetworks Inc. – Corporate Strategy
Epicore BioNetworks Inc. – SWOT Analysis
SWOT Analysis – Overview
Epicore BioNetworks Inc. – Strengths
Epicore BioNetworks Inc. – Weaknesses
Epicore BioNetworks Inc. – Opportunities
Epicore BioNetworks Inc. – Threats
Epicore BioNetworks Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Epicore BioNetworks Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Epicore BioNetworks Inc., Key Information
Epicore BioNetworks Inc., Key Ratios
Epicore BioNetworks Inc., Share Data
Epicore BioNetworks Inc., Major Products and Services
Epicore BioNetworks Inc., History
Epicore BioNetworks Inc., Key Employees
Epicore BioNetworks Inc., Key Employee Biographies
Epicore BioNetworks Inc., Key Operational Heads
Epicore BioNetworks Inc., Other Locations
Epicore BioNetworks Inc., Subsidiaries
Epicore BioNetworks Inc., Key Manufacturing facilities
Epicore BioNetworks Inc., Key Competitors
Epicore BioNetworks Inc., SWOT Analysis
Epicore BioNetworks Inc., Ratios based on current share price
Epicore BioNetworks Inc., Annual Ratios
Epicore BioNetworks Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Epicore BioNetworks Inc., Performance Chart
Epicore BioNetworks Inc., Ratio Charts

★海外企業調査レポート[Epicore BioNetworks Inc. (EBN):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Taeyoung Engineering & Construction Co., Ltd. (009410):企業財務及び戦略的SWOT分析
    Summary Taeyoung Engineering & Construction Co., Ltd. (Taeyoung), formerly Taeyoung Co., Ltd. is a construction company that undertakes civil works, building works, environmental plant works, housing works, leisure works and others. The company builds highways, bridges, railways, ports, subways, med …
  • OncBioMune Pharmaceuticals Inc (OBMP):企業のM&A・提携動向(医療分野)
    Summary OncBioMune Pharmaceuticals Inc (OncBioMune), formerly Quint Media Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The company’s products include biosimilars and vaccines developed for various cancer types such as breast, prostrate, renal and ovarian canc …
  • RAND A Technology Corporation (formerly RAND Worldwide, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' RAND A Technology Corporation ( …
  • CyberSource Corporation:企業の戦略的SWOT分析
    CyberSource Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Metcash Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Metcash Limited Mergers and Acq …
  • Traphaco Joint Stock Company (TRA):企業概要、財務及び戦略的SWOT分析
    Summary Traphaco Joint Stock Company (Traphaco JSC) is a pharmaceutical company. The company produces and distributes pharmaceutical, functional foodstuff and cosmetic products. It offers products such as antihistamines, antipyretics, antiseptics, antivirals, acide amine - vitamins and minerals, bon …
  • Heritage International Holdings Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Heritage International Holdings …
  • Assembly Biosciences Inc (ASMB)-製薬・医療分野:企業M&A・提携分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that discover, develops and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as chronic hepatitis B virus (HBV) and microbioti …
  • Midatech Pharma US Inc:企業のM&A・提携動向(医療機器分野)
    Summary Midatech Pharma US Inc (Midatech Pharma), formerly DARA BioSciences, Inc., is a pharmaceutical company which focuses on the development and commercialization of cancer treatment and supportive care products. The company’s product portfolio includes Soltamox for the treatment and prevention o …
  • Novatek (NVTK):企業のM&A・提携動向(エネルギー分野)
    Summary Novatek (Novatek) is an independent natural gas producer in Russia. The company explores, produces, processes, transports and markets natural gas and liquid hydrocarbons. Its upstream activities are concentrated in the prolific Yamal-Nenets Autonomous Region. Novatek’s core fields include Kh …
  • New York Independent System Operator Inc:企業の戦略的SWOT分析
    New York Independent System Operator Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Outside.in:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Outside.in Mergers and Acquisit …
  • Exoma Energy Limited (EXE):企業概要、財務及び戦略的SWOT分析
    Summary Exoma Energy Limited (Exoma Energy) is an oil and gas exploration company. The company explores and produces crude oil and natural gas. It operates five petroleum exploration permits in Galilee and Eromanga Basins. Exoma Energy’s projects include Galilee basin, conventional oil, coal seam ga …
  • U.S. Concrete, Inc. (USCR):企業概要、財務及び戦略的SWOT分析
    Summary U.S. Concrete, Inc. (USC) is a construction company. The company produces and markets ready-mixed concrete, aggregates, and concrete-related products and services to the construction industry. It operates through two segments; Ready-Mixed Concrete and Aggregate Products. USC’s Aggregate prod …
  • Connecticut Water Service, Inc. (CTWS):企業財務及び戦略的SWOT分析
    Summary Connecticut Water Service, Inc. (CWS) is a water utility that distributes and supplies drinking water and provides emergency water delivery services. The utility offers storage tanker, pump facilities, water supply on water outage, and refills storage tanks. Its services comprise contract op …
  • Nexus Energy Limited (NXS)(石油・ガス分野):企業M&A動向
    Summary Nexus Energy Limited (Nexus Energy) is an oil and gas exploration and production company. The company has interests in the Longtom gas field, which is located within the Gippsland Basin, offshore Victoria. It is the operator of the Longtom gas project and has administered the drilling of the …
  • Seres Therapeutics Inc (MCRB):企業財務及び戦略的SWOT分析
    Summary Seres Therapeutics Inc (Seres), formerly Seres Health, Inc., is a microbiome therapeutics platform company that develops a novel class of biological drugs. It is involved in creating a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condit …
  • Everist Genomics, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Everist Genomics, Inc. is a personalized medicine company. The company develops and commercializes medical diagnostic, prognostics and therapeutic selection technologies. Its lead product is the AngioDefender cardiovascular disease (CVD) diagnostic system, a non invasive device that combines …
  • Wuhan Kaidi Electric Power Co. Ltd. (000939):企業の財務及び戦略的SWOT分析
    Summary Wuhan Kaidi Electric Power Co., Ltd. (Wuhan Kaidi) is a renewable energy company that offers technology and services related to power supply and new energies. The company produces biomass energy from forestry and agricultural residues such as templates, rice hulls, leftover materials, fuel w …
  • Impel NeuroPharma Inc:企業のM&A・提携動向(医療機器分野)
    Summary Impel NeuroPharma Inc (Impel) is a medical device company that specializes in the development of precision olfactory delivery (POD) devices, which allow drug delivery to the upper nasal cavity for direct transport to brain. Its products accelerate the development of new drug treatments for v …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆